Cargando…
BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells
Increasing evidence indicates that BAF53a is crucial for embryonic development and maintenance of stemness, and may be associated with epithelial-mesenchymal transition (EMT), which suggests its involvement in cancer progression. However, the role of BAF53a in glioma remains unknown. In the present...
Autores principales: | Meng, Li, Wang, Xiaoyi, Liao, Weihua, Liu, Jianling, Liao, Yiwei, He, Qiongqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783583/ https://www.ncbi.nlm.nih.gov/pubmed/29039584 http://dx.doi.org/10.3892/or.2017.6019 |
Ejemplares similares
-
NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas
por: Sun, Huaiyu, et al.
Publicado: (2020) -
Baf53a is involved in survival of mouse ES cells, which can be compensated by Baf53b
por: Zhu, Bo, et al.
Publicado: (2017) -
Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial–mesenchymal transition
por: Zhang, Li, et al.
Publicado: (2017) -
GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
por: Huang, Qi, et al.
Publicado: (2020) -
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)